Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and manage chronic weight in adults with obesity
If you regain the weight you lost, your face may start looking fuller again, too
Many patients also notice reduced appetite
Adjustment When Switching If youre considering switching from Tirzepatide to Ozempic, there will be an adjustment period when you switch medications
Why it pairs well with Ozempic: TB-500 works through actin regulation and cellular signaling pathways unrelated to GLP-1 receptors
Despite the burgeoning global burden, effective disease-modifying therapies for MASH with fibrosis have only recently begun to emerge [3]